首页 | 本学科首页   官方微博 | 高级检索  
     

曲普瑞林对特发性中枢性性早熟女童的临床疗效和对骨龄的影响
引用本文:徐丽琴,洪庆荣,方圆. 曲普瑞林对特发性中枢性性早熟女童的临床疗效和对骨龄的影响[J]. 国际医药卫生导报, 2022, 28(6): 829-832. DOI: 10.3760/cma.j.issn.1007-1245.2022.06.024
作者姓名:徐丽琴  洪庆荣  方圆
作者单位:镇江市第一人民医院儿科,镇江 212002
摘    要:目的:研究曲普瑞林对特发性中枢性性早熟女童的临床疗效。方法:回顾性分析2018年1月至2020年12月在镇江市第一人民医院确诊为特发性中枢性性早熟女童68例的临床资料,年龄(8.21±1.55)岁,病程(13.42±2.97)个月。68例患儿均使用注射用曲普瑞林治疗,分别将治疗12个月前后相关资料进行对比分析。计量资料...

关 键 词:曲普瑞林  特发性中枢性性早熟  临床疗效  骨龄
收稿时间:2022-01-05

Clinical efficacy of triptorelin for girls with idiopathic central precocious puberty and its effect on bone age
Xu Liqin,Hong Qingrong,Fang Yuan. Clinical efficacy of triptorelin for girls with idiopathic central precocious puberty and its effect on bone age[J]. International Medicine & Health Guidance News, 2022, 28(6): 829-832. DOI: 10.3760/cma.j.issn.1007-1245.2022.06.024
Authors:Xu Liqin  Hong Qingrong  Fang Yuan
Affiliation:Department of Pediatrics, Zhenjiang First People's Hospital, Zhenjiang212002, China
Abstract:Objective To study the clinical effect of triptorelin for girls with idiopathiccentral precocious puberty. Methods The clinical data of68 girls diagnosed with idiopathic central precocious puberty in ZhenjiangFirst People's Hospital from January 2018 to December 2020 were retrospectivelyanalyzed, whose age was (8.21±1.55) years old and the course of disease was(13.42±2.97) months. All the 68 girls were treated with triptorelin forinjection, and the related data before and after 12 months of treatment werecompared and analyzed. Paired t testwas used to compare the measurement data before and after treatment. Results After 12 months of treatment, the body weight,height, and predicted adult height (PAH) in girls with idiopathic centralprecocious puberty increased, the growth rate tended to be normal, the bone ageprogression was delayed, and the bone age/age decreased (all P<0.05). After 12 months oftreatment, the baseline values of follicle stimulating hormone (FSH),luteinizing hormone (LH), and estradiol (E2) and uterine and ovarianvolumes in girls with idiopathic central precocious puberty decreased (all P<0.05). Before treatment, 31 girlshad 4 or more follicles with diameter greater than or equal to 4 mm, whichdecreased to 12 cases after 12 months of treatment, the secondary sexualcharacteristics were alleviated, and the adverse reactions were rare. Conclusions The use oftriptorelin for girls with idiopathic central precocious puberty can reduce thelevels of sex hormones, delay the display of secondary sexual characteristicsin girls, and achieve growth and development consistent with normal age, slowdown the premature closure of bones, and make girls develop normally, with fewadverse reactions, which is worthy of application and promotion.
Keywords:Triptorelin  Idiopathic central precocious puberty  Clinical efficacy  Bone age
本文献已被 万方数据 等数据库收录!
点击此处可从《国际医药卫生导报》浏览原始摘要信息
点击此处可从《国际医药卫生导报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号